$CPIX 8-K SEC Filings

Filed On	Filing
26 Oct 2026	8-K: Regulation FD Disclosure; Other Events On October 26, 2026, Cumberland Pharmaceuticals Inc. (the “Company” or “Cumberland”), an innovation-focused biopharmaceutical company developing new products for rare diseases, issued a press release providing an update on its ifetroban ...
23 Oct 2026	8-K: Other Events On October 23, 2026, Cumberland Pharmaceuticals Inc. (“Cumberland”) announced top-line results from its Phase 2a ASSIST-SSc trial evaluating oral ifetroban for patients with systemic sclerosis. These results support the safety and tolera...
28 Aug 2026	8-K: Regulation FD Disclosure
04 Aug 2026	8-K: Results of Operations and Financial Condition
13 Jul 2026	8-K: Other Events
01 Jul 2026	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +3 more
25 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
05 May 2026	8-K: Results of Operations and Financial Condition
24 Apr 2026	8-K: Submission of Matters to a Vote of Security Holders
23 Apr 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure +1 more
03 Mar 2026	8-K: Results of Operations and Financial Condition
04 Feb 2026	8-K: Other Events
24 Nov 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
04 Nov 2025	8-K: Results of Operations and Financial Condition
21 Oct 2025	8-K: Other Events
05 Aug 2025	8-K: Results of Operations and Financial Condition
06 May 2025	8-K: Results of Operations and Financial Condition
28 Apr 2025	8-K: Submission of Matters to a Vote of Security Holders
19 Mar 2025	8-K: Other Events
04 Mar 2025	8-K: Results of Operations and Financial Condition

Comments